全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

剪切波弹性成像联合tPSA及ALP对前列腺癌骨转移的诊断价值
Diagnostic Value of Shear Wave Elastography Combined with tPSA and ALP in Prostate Cancer Bone Metastasis

DOI: 10.12677/acm.2025.154923, PP. 225-233

Keywords: 剪切波弹性成像,前列腺癌骨转移,前列腺特异性抗原,碱性磷酸酶
Shear Wave Elastography
, Prostate Cancer Bone Metastasis, Prostate Specific Antigen, Alkaline Phosphatase

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨经直肠剪切波弹性成像(SWE)联合总前列腺特异性抗原(tPSA)及ALP (碱性磷酸酶)等临床指标对前列腺癌骨转移的诊断价值。方法:收集2020年10月至2023年7月于延安大学附属医院就诊的62例超声引导下穿刺活检确诊为前列腺癌的患者,并收集临床资料,通过超声剪切波弹性成像测定弹性指标Emax、Emean、Emin,根据全身骨扫描结果将研究对象分为骨转移阴性组和阳性组。比较两组一般临床特征、实验室指标及SWE参数差异,使用logistic回归确定前列腺癌骨转移发生的临床独立危险因素,通过受试者工作特征(ROC)曲线分析各指标的截断值、敏感度及特异性等。结果:62例患者中,骨转移组15例,非骨转移组47例。前列腺癌骨转移组患者血清tPSA、fPSA、%fPSA、PSAD及ALP均高于非骨转移组;当Emean ≥ 100.48 kPa时,诊断前列腺癌骨转移的灵敏度、特异度分别为0.867、0.830;随着Gleason评分及PI-RADS评分等升高,骨转移组人数占比也随之升高;单因素及多因素Logistic回归分析表明,tPSA、ALP及Emean是前列腺癌骨转移的独立危险因素,联合此三者时诊断前列腺癌骨转移的曲线下面积(AUC)为0.959,灵敏度为0.930、特异度为0.894,均高于Emean与tPSA、ALP单独诊断。结论:经直肠剪切波弹性成像(SWE)参数Emean对前列腺癌患者骨转移的诊断有一定价值,联合总前列腺特异性抗原(tPSA)、碱性磷酸酶(ALP)能够提高对前列腺癌骨转移的诊断效能,有助于临床早期预测前列腺癌患者骨转移的风险,评估全身骨扫描检查的必要性。
Objective: To explore the diagnostic value of transrectal shear wave elastography (SWE) combined with clinical indicators such as total prostate-specific antigen (tPSA) and ALP (alkaline phosphatase) for prostate cancer bone metastasis. Methods: A total of 62 patients diagnosed with prostate cancer by ultrasound-guided puncture biopsy who visited the Affiliated Hospital of Yan’an University from October 2020 to July 2023 were enrolled, and clinical data were collected. The elasticity indicators Emax, Emean, and Emin were measured by ultrasound shear wave elastography. According to the results of whole-body bone scan, the subjects were divided into a bone metastasis negative group and a positive group. The general clinical characteristics, laboratory indicators, and SWE parameters of the two groups were compared. Logistic regression was used to determine the clinical independent risk factors for prostate cancer bone metastasis. The cutoff value, sensitivity, and specificity of each indicator were analyzed by the receiver operating characteristic (ROC) curve. Results: Among the 62 patients, 15 were in the bone metastasis group and 47 were in the non-bone metastasis group. The serum tPSA, fPSA, %fPSA, PSAD and ALP of patients with prostate cancer bone metastasis were higher than those of patients without bone metastasis. When Emean ≥ 100.48 kPa, the sensitivity and specificity of diagnosing prostate cancer bone metastasis were 0.867 and 0.830 respectively. With the increase of Gleason score and PI-RADS score, the proportion of patients with bone metastasis also increased. Univariate and multivariate Logistic regression analysis showed that tPSA, ALP and Emean were independent risk factors

References

[1]  Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
[2]  李宁, 肖国有. 前列腺癌骨转移治疗的研究进展[J]. 肿瘤防治研究, 2020, 47(8): 641-646.
[3]  中国抗癌协会泌尿男生殖系统肿瘤专业委员会. 前列腺癌骨转移和骨相关疾病临床诊疗专家共识(2021版) [J]. 中华肿瘤杂志, 2021, 43(10): 1016-1026.
[4]  Bercoff, J., Tanter, M. and Fink, M. (2004) Supersonic Shear Imaging: A New Technique for Soft Tissue Elasticity Mapping. IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control, 51, 396-409.
https://doi.org/10.1109/tuffc.2004.1295425
[5]  Kataoka, A., Yuasa, T., Kageyama, S., Tsuchiya, N., Habuchi, T., Iwaki, H., et al. (2006) Diagnosis of Bone Metastasis in Men with Prostate Cancer by Measurement of Serum ICTP in Combination with Alkali Phosphatase and Prostate-Specific Antigen. Clinical Oncology, 18, 480-484.
https://doi.org/10.1016/j.clon.2006.02.010
[6]  Stokkel, M.P.M., Zwinderman, A.H., Zwartendijk, J., Pauwels, E.K.J. and Van Eck-Smit, B.L.F. (1998) The Value of Pretreatment Clinical and Biochemical Parameters in Staging and Prognostic Stratification of Patients with Newly Diagnosed Prostate Carcinoma. The International Journal of Biological Markers, 13, 70-76.
https://doi.org/10.1177/172460089801300202
[7]  Park, H., Lee, S.W., Song, G., Kang, T.W., Jung, J.H., Chung, H.C., et al. (2018) Diagnostic Performance of %[−2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-Institutional Study. Journal of Korean Medical Science, 33, e94.
https://doi.org/10.3346/jkms.2018.33.e94
[8]  Briganti, A., Passoni, N., Ferrari, M., Capitanio, U., Suardi, N., Gallina, A., et al. (2010) When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool. European Urology, 57, 551-558.
https://doi.org/10.1016/j.eururo.2009.12.023
[9]  林军明, 刘家明, 周扬, 等. 前列腺癌骨转移的特点及其相关危险因素分析[J]. 解放军医学杂志, 2017, 42(8): 707-711.
[10]  Rao, S.R., Snaith, A.E., Marino, D., et al. (2017) Tumour-Derived Alkaline Phosphatase Regulates Tumour Growth, Epithelial Plasticity and Disease-Free Survival in Metastatic Prostate Cancer. British Journal of Cancer, 116, 227-236.
[11]  Wei, R.J., Li, T.Y., Yang, X.C., Jia, N., Yang, X.L. and Song, H.B. (2016) Serum Levels of PSA, ALP, ICTP, and BSP in Prostate Cancer Patients and the Significance of ROC Curve in the Diagnosis of Prostate Cancer Bone Metastases. Genetics and Molecular Research, 15, gmr.15027707.
https://doi.org/10.4238/gmr.15027707
[12]  龙玉屏, 黄珊珊, 赵中千, 等. 经直肠常规超声, 实时组织弹性成像及超声造影联合应用对侵袭性前列腺癌的诊断价值[J]. 临床超声医学杂志, 2022, 24(4): 291-294.
[13]  王云帆, 缪琦, 张晋夏, 等. 穿刺活检前列腺癌119例病理形态、Gleason分级及预后分组[J]. 诊断病理学杂志, 2018, 25(1): 17-21.
[14]  Li, X.B., Zhang, L., Rao, T.W., Chen, J., Leng, Y.J. and Huang, P. (2017) Low Serum Testosterone Level Does Not Predict Bone Metastasis of Prostate Cancer. National Journal of Andrology, 23, 212-216.
[15]  陆海健, 周勇, 林红萍, 等. 99mTc-MDP SPECT/CT显像定量分析对前列腺癌骨转移的诊断价值以及SUV的一致性研究[J]. 浙江医学, 2023, 45(11): 1152-1156.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133